English

Targeted Medical Pharma, Inc.

EDGAR

TRGM Annual report (10-K) · filed 2016-04-14

38 filing records in this dataset, filed from 2008-05-15 to 2016-04-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.29 million USD

2015 Q4 · USD

Exact inputs and evidence

Revenue: 5260941 USD Source
Revenue: 3972283 USD Source

Operating margin

-28.48%

2015 Q4 · %

Exact inputs and evidence

Operating Income: -2029773 USD Source
Operating Income: -1662812 USD Source
Revenue: 5260941 USD Source
Revenue: 3972283 USD Source

Operating cash flow

76.5 thousand USD

2015 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -1278617 USD Source
Operating Cash Flow: -1355160 USD Source

Cash and cash equivalents: 82.6 thousand USD 2015-12-31 Source
Exact value

82643 USD
Long-term debt including current maturities: Not available
Shares outstanding: 27.7 million shares 2015-12-31 Source
Exact value

27730227 shares

Reported share-count change

3.59% · 961 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

26768756 shares · 2014-12-31· Source
27730227 shares · 2015-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

5.26 million USD

2015-01-01 – 2015-12-31

Exact inputs and evidence

Revenue: 1067888 USD · 2015-01-01 – 2015-03-31 Source
Revenue: 1342078 USD · 2015-04-01 – 2015-06-30 Source
Revenue: 1562317 USD · 2015-07-01 – 2015-09-30 Source
Revenue: 5260941 USD · 2015-01-01 – 2015-12-31 Source
Revenue: 3972283 USD · 2015-01-01 – 2015-09-30 Source

Net income

-3.04 million USD

2015-01-01 – 2015-12-31

Exact inputs and evidence

Net income: -1678409 USD · 2015-01-01 – 2015-03-31 Source
Net income: -546170 USD · 2015-04-01 – 2015-06-30 Source
Net income: -237758 USD · 2015-07-01 – 2015-09-30 Source
Net income: -3043810 USD · 2015-01-01 – 2015-12-31 Source
Net income: -2462337 USD · 2015-01-01 – 2015-09-30 Source

Operating cash flow

-1.28 million USD

2015-01-01 – 2015-12-31

Exact inputs and evidence

Operating cash flow: -1461442 USD · 2015-01-01 – 2015-03-31 Source
Operating cash flow: -1487386 USD · 2015-01-01 – 2015-06-30 Source
Operating cash flow: -1461442 USD · 2015-01-01 – 2015-03-31 Source
Operating cash flow: -1355160 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -1487386 USD · 2015-01-01 – 2015-06-30 Source
Operating cash flow: -1278617 USD · 2015-01-01 – 2015-12-31 Source
Operating cash flow: -1355160 USD · 2015-01-01 – 2015-09-30 Source

Capital expenditure

38 thousand USD

2013-01-01 – 2013-12-31

Exact inputs and evidence

Capital expenditure: 11208 USD · 2013-01-01 – 2013-03-31 Source
Capital expenditure: 23481 USD · 2013-01-01 – 2013-06-30 Source
Capital expenditure: 11208 USD · 2013-01-01 – 2013-03-31 Source
Capital expenditure: 27277 USD · 2013-01-01 – 2013-09-30 Source
Capital expenditure: 23481 USD · 2013-01-01 – 2013-06-30 Source
Capital expenditure: 37990 USD · 2013-01-01 – 2013-12-31 Source
Capital expenditure: 27277 USD · 2013-01-01 – 2013-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2016-04-14.

Financial data available through: 2015-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2015-12-31
Operating income: 6 of 11 periods available· newest 2015-12-31
Net income: 9 of 11 periods available· newest 2015-12-31
Operating cash flow: 9 of 11 periods available· newest 2015-12-31
Capital expenditure: 4 of 11 periods available· newest 2013-12-31
Total assets: 9 of 11 periods available· newest 2015-12-31
Total liabilities: 9 of 11 periods available· newest 2015-12-31
Current assets: 6 of 11 periods available· newest 2015-12-31
Current liabilities: 6 of 11 periods available· newest 2015-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2015-12-31
long term debt: No compatible figures in this window
Shares outstanding: 6 of 11 periods available· newest 2015-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-26%

Prior period

USD 7.11 million

2014-01-01 – 2014-12-31
Current period

USD 5.26 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

5260941 − 7112359 = -1851418 USD

7112359 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
5260941 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Targeted Medical Pharma, Inc. · 2015-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Year-over-year change in Revenue: -1851418 USD Concept: fundies:Revenue Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 5260941 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000149315216008933/trgm-20151231.xml#106539 Filing: 000149315216008933 Input fundies:Revenue: 7112359 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000149315216008933/trgm-20151231.xml#107533 Filing: 000149315216008933
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 851,199

Prior period

−USD 3.9 million

2014-01-01 – 2014-12-31
Current period

−USD 3.04 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-3043810 − -3895009 = 851199 USD

-3895009 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-3043810 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Targeted Medical Pharma, Inc. · 2015-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Year-over-year change in Net income: 851199 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -3043810 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000149315216008933/trgm-20151231.xml#110810 Filing: 000149315216008933 Input fundies:NetIncome: -3895009 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000149315216008933/trgm-20151231.xml#111541 Filing: 000149315216008933
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-263.9%

Prior period

USD 780,314

2014-01-01 – 2014-12-31
Current period

−USD 1.28 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-1278617 − 780314 = -2058931 USD

780314 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-1278617 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Targeted Medical Pharma, Inc. · 2015-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Year-over-year change in Operating cash flow: -2058931 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1278617 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000149315216008933/trgm-20151231.xml#586368 Filing: 000149315216008933 Input fundies:OperatingCashFlow: 780314 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000149315216008933/trgm-20151231.xml#586553 Filing: 000149315216008933
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2015 2015-01-01 – 2015-12-31

Revenue USD 5.26 million 100% of revenue
Cost of revenue USD 466,214 8.9% of revenue
Operating expenses USD 5.2 million 99% of revenue
Other operating costs Derived USD 1.63 million 31% of revenue
Operating income −USD 2.03 million −39% of revenue
Tax, interest and other Derived USD 1.01 million 19% of revenue
Net income −USD 3.04 million −58% of revenue

Cash

Operating cash flow −USD 1.28 million −24% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2008 Not shown: operating income or net income is not reported.
2009 Not shown: operating income or net income is not reported.
2010 Not shown: operating income or net income is not reported.
2010 Operating loss: operating costs were 121% of revenue.
2011 Operating loss: operating costs were 166% of revenue.
2012 Operating loss: operating costs were 184% of revenue.
2013 Operating loss: operating costs were 140% of revenue.
2014 Operating loss: operating costs were 137% of revenue.
2015 Operating loss: operating costs were 139% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2008 2007-11-01 – 2008-10-31	0	Unavailable	Unavailable	Unavailable	-7899	Unavailable	Source 2007-11-01 – 2008-10-31: 0 USD Inspect Revenue Open source 2007-11-01 – 2008-10-31: -7899 USD Inspect Net Income Open source 2007-11-01 – 2008-10-31: -7382 USD Inspect Operating Cash Flow Open source
2009 2008-11-01 – 2009-10-31	0	Unavailable	Unavailable	Unavailable	-7903	Unavailable	Source 2008-11-01 – 2009-10-31: 0 USD Inspect Revenue Open source 2008-11-01 – 2009-10-31: -7903 USD Inspect Net Income Open source 2008-11-01 – 2009-10-31: -2340 USD Inspect Operating Cash Flow Open source
2010 2009-11-01 – 2010-10-31	0	Unavailable	Unavailable	Unavailable	-3972	Unavailable	Source 2009-11-01 – 2010-10-31: 0 USD Inspect Revenue Open source 2009-11-01 – 2010-10-31: -3972 USD Inspect Net Income Open source 2009-11-01 – 2010-10-31: -6095 USD Inspect Operating Cash Flow Open source
2010 2010-01-01 – 2010-12-31	7622477	9198403 Derived	-1575926	-1069813 Derived	-506113	382833 Derived	Source 2010-01-01 – 2010-12-31: 7622477 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -1575926 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -506113 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: 579400 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 196567 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	8809668	14590206 Derived	-5780538	-1603488 Derived	-4177050	-2667875 Derived	Source 2011-01-01 – 2011-12-31: 8809668 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -5780538 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -4177050 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -2585590 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 82285 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	7296401	13436210 Derived	-6139809	3446373 Derived	-9586182	-2488933 Derived	Source 2012-01-01 – 2012-12-31: 7296401 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -6139809 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -9586182 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -2373401 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 115532 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	9555562	13396508 Derived	-3840946	5496672 Derived	-9337618	-2084576 Derived	Source 2013-01-01 – 2013-12-31: 9555562 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -3840946 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -9337618 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -2046586 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 37990 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	7112359	9723310 Derived	-2610951	1284058 Derived	-3895009	Unavailable	Source 2014-01-01 – 2014-12-31: 7112359 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -2610951 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -3895009 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: 780314 USD Inspect Operating Cash Flow Open source
2015 2015-01-01 – 2015-12-31	5260941	7290714 Derived	-2029773	1014037 Derived	-3043810	Unavailable	Source 2015-01-01 – 2015-12-31: 5260941 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -2029773 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -3043810 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -1278617 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 5.3M 2015

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-10-31	Revenue	0	Revenue: 0 Open source
20092009-10-31	Revenue	0	Revenue: 0 Open source
20102010-10-31	Revenue	0	Revenue: 0 Open source
20102010-12-31	Revenue	7622477	Revenue: 7622477 Open source
20112011-12-31	Revenue	8809668	Revenue: 8809668 Open source
20122012-12-31	Revenue	7296401	Revenue: 7296401 Open source
20132013-12-31	Revenue	9555562	Revenue: 9555562 Open source
20142014-12-31	Revenue	7112359	Revenue: 7112359 Open source
20152015-12-31	Revenue	5260941	Revenue: 5260941 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-26% 2015

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20082008-10-31	Year over year	No prior comparable period	Revenue: 0 Open source
20092009-10-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20102010-10-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20102010-12-31	Year over year	No prior comparable period	Revenue: 7622477 Open source
20112011-12-31	Year over year	15.6%	Revenue: 8809668 Open source Revenue: 7622477 Open source
20122012-12-31	Year over year	-17.2%	Revenue: 7296401 Open source Revenue: 8809668 Open source
20132013-12-31	Year over year	31%	Revenue: 9555562 Open source Revenue: 7296401 Open source
20142014-12-31	Year over year	-25.6%	Revenue: 7112359 Open source Revenue: 9555562 Open source
20152015-12-31	Year over year	-26%	Revenue: 5260941 Open source Revenue: 7112359 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -38.6% 2015

Net margin -57.9% 2015

Free cash flow margin -21.8% 2013

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2008-10-31	Operating margin	Not reported	Revenue: 0 Open source
2009-10-31	Operating margin	Not reported	Revenue: 0 Open source
2010-10-31	Operating margin	Not reported	Revenue: 0 Open source
20102010-12-31	Operating margin	-20.7%	Operating Income: -1575926 Open source Revenue: 7622477 Open source
20112011-12-31	Operating margin	-65.6%	Operating Income: -5780538 Open source Revenue: 8809668 Open source
20122012-12-31	Operating margin	-84.1%	Operating Income: -6139809 Open source Revenue: 7296401 Open source
20132013-12-31	Operating margin	-40.2%	Operating Income: -3840946 Open source Revenue: 9555562 Open source
20142014-12-31	Operating margin	-36.7%	Operating Income: -2610951 Open source Revenue: 7112359 Open source
20152015-12-31	Operating margin	-38.6%	Operating Income: -2029773 Open source Revenue: 5260941 Open source
20082008-10-31	Net margin	Not reported	Net Income: -7899 Open source Revenue: 0 Open source
20092009-10-31	Net margin	Not reported	Net Income: -7903 Open source Revenue: 0 Open source
20102010-10-31	Net margin	Not reported	Net Income: -3972 Open source Revenue: 0 Open source
20102010-12-31	Net margin	-6.6%	Net Income: -506113 Open source Revenue: 7622477 Open source
20112011-12-31	Net margin	-47.4%	Net Income: -4177050 Open source Revenue: 8809668 Open source
20122012-12-31	Net margin	-131.4%	Net Income: -9586182 Open source Revenue: 7296401 Open source
20132013-12-31	Net margin	-97.7%	Net Income: -9337618 Open source Revenue: 9555562 Open source
20142014-12-31	Net margin	-54.8%	Net Income: -3895009 Open source Revenue: 7112359 Open source
20152015-12-31	Net margin	-57.9%	Net Income: -3043810 Open source Revenue: 5260941 Open source
20082008-10-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -7382 Open source
20092009-10-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -2340 Open source
20102010-10-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -6095 Open source
20102010-12-31	Free cash flow margin	5%	Revenue: 7622477 Open source Operating Cash Flow: 579400 Open source Capital Expenditure: 196567 Open source
20112011-12-31	Free cash flow margin	-30.3%	Revenue: 8809668 Open source Operating Cash Flow: -2585590 Open source Capital Expenditure: 82285 Open source
20122012-12-31	Free cash flow margin	-34.1%	Revenue: 7296401 Open source Operating Cash Flow: -2373401 Open source Capital Expenditure: 115532 Open source
20132013-12-31	Free cash flow margin	-21.8%	Revenue: 9555562 Open source Operating Cash Flow: -2046586 Open source Capital Expenditure: 37990 Open source
20142014-12-31	Free cash flow margin	Not reported	Revenue: 7112359 Open source Operating Cash Flow: 780314 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 5260941 Open source Operating Cash Flow: -1278617 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.3M 2015

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-10-31	Operating cash flow	-7382	Operating Cash Flow: -7382 Open source
20092009-10-31	Operating cash flow	-2340	Operating Cash Flow: -2340 Open source
20102010-10-31	Operating cash flow	-6095	Operating Cash Flow: -6095 Open source
20102010-12-31	Operating cash flow	579400	Operating Cash Flow: 579400 Open source
20112011-12-31	Operating cash flow	-2585590	Operating Cash Flow: -2585590 Open source
20122012-12-31	Operating cash flow	-2373401	Operating Cash Flow: -2373401 Open source
20132013-12-31	Operating cash flow	-2046586	Operating Cash Flow: -2046586 Open source
20142014-12-31	Operating cash flow	780314	Operating Cash Flow: 780314 Open source
20152015-12-31	Operating cash flow	-1278617	Operating Cash Flow: -1278617 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -2.1M 2013

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-10-31	Free cash flow	Unavailable	Operating Cash Flow: -7382 Open source
20092009-10-31	Free cash flow	Unavailable	Operating Cash Flow: -2340 Open source
20102010-10-31	Free cash flow	Unavailable	Operating Cash Flow: -6095 Open source
20102010-12-31	Free cash flow	382833	Operating Cash Flow: 579400 Open source Capital Expenditure: 196567 Open source
20112011-12-31	Free cash flow	-2667875	Operating Cash Flow: -2585590 Open source Capital Expenditure: 82285 Open source
20122012-12-31	Free cash flow	-2488933	Operating Cash Flow: -2373401 Open source Capital Expenditure: 115532 Open source
20132013-12-31	Free cash flow	-2084576	Operating Cash Flow: -2046586 Open source Capital Expenditure: 37990 Open source
20142014-12-31	Free cash flow	Unavailable	Operating Cash Flow: 780314 Open source
20152015-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1278617 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

632.3% 2015

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20082008-10-31	Liabilities / assets	328.4%	Total Liabilities: 6841 Open source Total Assets: 2083 Open source
20092009-10-31	Liabilities / assets	Not reported	Total Liabilities: 12661 Open source Total Assets: 0 Open source
20102010-10-31	Liabilities / assets	141.2%	Total Liabilities: 56957 Open source Total Assets: 40324 Open source
20102010-12-31	Liabilities / assets	44.7%	Total Liabilities: 2660339 Open source Total Assets: 5951609 Open source
20112011-12-31	Liabilities / assets	93.2%	Total Liabilities: 8370343 Open source Total Assets: 8977776 Open source
20122012-12-31	Liabilities / assets	118.8%	Total Liabilities: 12630783 Open source Total Assets: 10628747 Open source
20132013-12-31	Liabilities / assets	240.4%	Total Liabilities: 12015451 Open source Total Assets: 4997753 Open source
20142014-12-31	Liabilities / assets	498.8%	Total Liabilities: 12471870 Open source Total Assets: 2500296 Open source
20152015-12-31	Liabilities / assets	632.3%	Total Liabilities: 15345981 Open source Total Assets: 2427110 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.06× 2015

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2008-10-31	Current assets / current liabilities	Not reported	No source recorded
2009-10-31	Current assets / current liabilities	Not reported	No source recorded
2010-10-31	Current assets / current liabilities	Not reported	No source recorded
20102010-12-31	Current assets / current liabilities	1.14×	Current Assets: 2202638 Open source Current Liabilities: 1928511 Open source
20112011-12-31	Current assets / current liabilities	0.39×	Current Assets: 2899717 Open source Current Liabilities: 7483293 Open source
20122012-12-31	Current assets / current liabilities	0.21×	Current Assets: 2529165 Open source Current Liabilities: 12245074 Open source
20132013-12-31	Current assets / current liabilities	0.23×	Current Assets: 2629518 Open source Current Liabilities: 11260623 Open source
20142014-12-31	Current assets / current liabilities	0.04×	Current Assets: 533959 Open source Current Liabilities: 12349580 Open source
20152015-12-31	Current assets / current liabilities	0.06×	Current Assets: 832985 Open source Current Liabilities: 14675078 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2008 2007-11-01 – 2008-10-31	−USD 7,899 Exact value Exact value: -7899 USD 2007-11-01 – 2008-10-31: -7899 USD Inspect Net Income Open source Share or cite Citation for Net Income · Targeted Medical Pharma, Inc. · 2008-10-31 Targeted Medical Pharma, Inc. (edgar:1420030) Net Income: -7899 USD Concept: fundies:NetIncome Period: 2007-11-01 to 2008-10-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3ANetIncome&period=2008-10-31&surface=latest&period_type=duration&start=2007-11-01&unit=USD&dimensions= Input fundies:NetIncome: -7899 USD (2007-11-01 to 2008-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/0001387131-10-000299.txt#1893 The citation records this snapshot. The page link may show a newer release later.	−USD 7,382 Exact value Exact value: -7382 USD 2007-11-01 – 2008-10-31: -7382 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Targeted Medical Pharma, Inc. · 2008-10-31 Targeted Medical Pharma, Inc. (edgar:1420030) Operating Cash Flow: -7382 USD Concept: fundies:OperatingCashFlow Period: 2007-11-01 to 2008-10-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3AOperatingCashFlow&period=2008-10-31&surface=latest&period_type=duration&start=2007-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7382 USD (2007-11-01 to 2008-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/0001387131-10-000299.txt#1991 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2009 2008-11-01 – 2009-10-31	−USD 7,903 Exact value Exact value: -7903 USD 2008-11-01 – 2009-10-31: -7903 USD Inspect Net Income Open source Share or cite Citation for Net Income · Targeted Medical Pharma, Inc. · 2009-10-31 Targeted Medical Pharma, Inc. (edgar:1420030) Net Income: -7903 USD Concept: fundies:NetIncome Period: 2008-11-01 to 2009-10-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3ANetIncome&period=2009-10-31&surface=latest&period_type=duration&start=2008-11-01&unit=USD&dimensions= Input fundies:NetIncome: -7903 USD (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/0001387131-10-001352.txt#3463 The citation records this snapshot. The page link may show a newer release later.	−USD 2,340 Exact value Exact value: -2340 USD 2008-11-01 – 2009-10-31: -2340 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Targeted Medical Pharma, Inc. · 2009-10-31 Targeted Medical Pharma, Inc. (edgar:1420030) Operating Cash Flow: -2340 USD Concept: fundies:OperatingCashFlow Period: 2008-11-01 to 2009-10-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3AOperatingCashFlow&period=2009-10-31&surface=latest&period_type=duration&start=2008-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2340 USD (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/0001387131-10-001352.txt#3555 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2009-11-01 – 2010-10-31	−USD 3,972 Exact value Exact value: -3972 USD 2009-11-01 – 2010-10-31: -3972 USD Inspect Net Income Open source Share or cite Citation for Net Income · Targeted Medical Pharma, Inc. · 2010-10-31 Targeted Medical Pharma, Inc. (edgar:1420030) Net Income: -3972 USD Concept: fundies:NetIncome Period: 2009-11-01 to 2010-10-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3ANetIncome&period=2010-10-31&surface=latest&period_type=duration&start=2009-11-01&unit=USD&dimensions= Input fundies:NetIncome: -3972 USD (2009-11-01 to 2010-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/0001387131-10-001352.txt#3463 The citation records this snapshot. The page link may show a newer release later.	−USD 6,095 Exact value Exact value: -6095 USD 2009-11-01 – 2010-10-31: -6095 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Targeted Medical Pharma, Inc. · 2010-10-31 Targeted Medical Pharma, Inc. (edgar:1420030) Operating Cash Flow: -6095 USD Concept: fundies:OperatingCashFlow Period: 2009-11-01 to 2010-10-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3AOperatingCashFlow&period=2010-10-31&surface=latest&period_type=duration&start=2009-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6095 USD (2009-11-01 to 2010-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/0001387131-10-001352.txt#3555 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	−USD 506,113 Exact value Exact value: -506113 USD 2010-01-01 – 2010-12-31: -506113 USD Inspect Net Income Open source Share or cite Citation for Net Income · Targeted Medical Pharma, Inc. · 2010-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Net Income: -506113 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -506113 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000114420413008313/ck0001420030-20120930.xml#265596 Filing: 000114420413008313 The citation records this snapshot. The page link may show a newer release later.	USD 579,400 Exact value Exact value: 579400 USD 2010-01-01 – 2010-12-31: 579400 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Targeted Medical Pharma, Inc. · 2010-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Operating Cash Flow: 579400 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 579400 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000114420413008313/ck0001420030-20120930.xml#295090 Filing: 000114420413008313 The citation records this snapshot. The page link may show a newer release later.	USD 196,567 Exact value Exact value: 196567 USD 2010-01-01 – 2010-12-31: 196567 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Targeted Medical Pharma, Inc. · 2010-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Capital Expenditure: 196567 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 196567 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000114420413008313/ck0001420030-20120930.xml#297070 Filing: 000114420413008313 The citation records this snapshot. The page link may show a newer release later.	USD 382,833 Calculation and evidence 579400 − 196567 USD Exact free cash flow: 382833 USD 2010-01-01 – 2010-12-31: 579400 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 196567 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Targeted Medical Pharma, Inc. · 2010-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Free cash flow: 382833 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 579400 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000114420413008313/ck0001420030-20120930.xml#295090 Filing: 000114420413008313 Input fundies:CapitalExpenditure: 196567 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000114420413008313/ck0001420030-20120930.xml#297070 Filing: 000114420413008313 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 4.18 million Exact value Exact value: -4177050 USD 2011-01-01 – 2011-12-31: -4177050 USD Inspect Net Income Open source Share or cite Citation for Net Income · Targeted Medical Pharma, Inc. · 2011-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Net Income: -4177050 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4177050 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000114420413019247/trgm-20121231.xml#164466 Filing: 000114420413019247 The citation records this snapshot. The page link may show a newer release later.	−USD 2.59 million Exact value Exact value: -2585590 USD 2011-01-01 – 2011-12-31: -2585590 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Targeted Medical Pharma, Inc. · 2011-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Operating Cash Flow: -2585590 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2585590 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000114420413019247/trgm-20121231.xml#185546 Filing: 000114420413019247 The citation records this snapshot. The page link may show a newer release later.	USD 82,285 Exact value Exact value: 82285 USD 2011-01-01 – 2011-12-31: 82285 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Targeted Medical Pharma, Inc. · 2011-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Capital Expenditure: 82285 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 82285 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000114420413019247/trgm-20121231.xml#186534 Filing: 000114420413019247 The citation records this snapshot. The page link may show a newer release later.	−USD 2.67 million Calculation and evidence -2585590 − 82285 USD Exact free cash flow: -2667875 USD 2011-01-01 – 2011-12-31: -2585590 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 82285 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Targeted Medical Pharma, Inc. · 2011-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Free cash flow: -2667875 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2585590 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000114420413019247/trgm-20121231.xml#185546 Filing: 000114420413019247 Input fundies:CapitalExpenditure: 82285 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000114420413019247/trgm-20121231.xml#186534 Filing: 000114420413019247 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 9.59 million Exact value Exact value: -9586182 USD 2012-01-01 – 2012-12-31: -9586182 USD Inspect Net Income Open source Share or cite Citation for Net Income · Targeted Medical Pharma, Inc. · 2012-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Net Income: -9586182 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9586182 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000149315214000948/trgm-20131231.xml#94878 Filing: 000149315214000948 The citation records this snapshot. The page link may show a newer release later.	−USD 2.37 million Exact value Exact value: -2373401 USD 2012-01-01 – 2012-12-31: -2373401 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Targeted Medical Pharma, Inc. · 2012-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Operating Cash Flow: -2373401 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2373401 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000149315214000948/trgm-20131231.xml#102701 Filing: 000149315214000948 The citation records this snapshot. The page link may show a newer release later.	USD 115,532 Exact value Exact value: 115532 USD 2012-01-01 – 2012-12-31: 115532 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Targeted Medical Pharma, Inc. · 2012-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Capital Expenditure: 115532 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 115532 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000149315214000948/trgm-20131231.xml#103397 Filing: 000149315214000948 The citation records this snapshot. The page link may show a newer release later.	−USD 2.49 million Calculation and evidence -2373401 − 115532 USD Exact free cash flow: -2488933 USD 2012-01-01 – 2012-12-31: -2373401 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 115532 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Targeted Medical Pharma, Inc. · 2012-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Free cash flow: -2488933 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2373401 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000149315214000948/trgm-20131231.xml#102701 Filing: 000149315214000948 Input fundies:CapitalExpenditure: 115532 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000149315214000948/trgm-20131231.xml#103397 Filing: 000149315214000948 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 9.34 million Exact value Exact value: -9337618 USD 2013-01-01 – 2013-12-31: -9337618 USD Inspect Net Income Open source Share or cite Citation for Net Income · Targeted Medical Pharma, Inc. · 2013-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Net Income: -9337618 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9337618 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000149315215001421/trgm-20141231.xml#102159 Filing: 000149315215001421 The citation records this snapshot. The page link may show a newer release later.	−USD 2.05 million Exact value Exact value: -2046586 USD 2013-01-01 – 2013-12-31: -2046586 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Targeted Medical Pharma, Inc. · 2013-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Operating Cash Flow: -2046586 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2046586 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000149315215001421/trgm-20141231.xml#474414 Filing: 000149315215001421 The citation records this snapshot. The page link may show a newer release later.	USD 37,990 Exact value Exact value: 37990 USD 2013-01-01 – 2013-12-31: 37990 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Targeted Medical Pharma, Inc. · 2013-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Capital Expenditure: 37990 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 37990 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000149315215001421/trgm-20141231.xml#408190 Filing: 000149315215001421 The citation records this snapshot. The page link may show a newer release later.	−USD 2.08 million Calculation and evidence -2046586 − 37990 USD Exact free cash flow: -2084576 USD 2013-01-01 – 2013-12-31: -2046586 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 37990 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Targeted Medical Pharma, Inc. · 2013-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Free cash flow: -2084576 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2046586 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000149315215001421/trgm-20141231.xml#474414 Filing: 000149315215001421 Input fundies:CapitalExpenditure: 37990 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000149315215001421/trgm-20141231.xml#408190 Filing: 000149315215001421 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 3.9 million Exact value Exact value: -3895009 USD 2014-01-01 – 2014-12-31: -3895009 USD Inspect Net Income Open source Share or cite Citation for Net Income · Targeted Medical Pharma, Inc. · 2014-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Net Income: -3895009 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3895009 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000149315216008933/trgm-20151231.xml#111541 Filing: 000149315216008933 The citation records this snapshot. The page link may show a newer release later.	USD 780,314 Exact value Exact value: 780314 USD 2014-01-01 – 2014-12-31: 780314 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Targeted Medical Pharma, Inc. · 2014-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Operating Cash Flow: 780314 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 780314 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000149315216008933/trgm-20151231.xml#586553 Filing: 000149315216008933 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2015-01-01 – 2015-12-31	−USD 3.04 million Exact value Exact value: -3043810 USD 2015-01-01 – 2015-12-31: -3043810 USD Inspect Net Income Open source Share or cite Citation for Net Income · Targeted Medical Pharma, Inc. · 2015-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Net Income: -3043810 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3043810 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000149315216008933/trgm-20151231.xml#110810 Filing: 000149315216008933 The citation records this snapshot. The page link may show a newer release later.	−USD 1.28 million Exact value Exact value: -1278617 USD 2015-01-01 – 2015-12-31: -1278617 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Targeted Medical Pharma, Inc. · 2015-12-31 Targeted Medical Pharma, Inc. (edgar:1420030) Operating Cash Flow: -1278617 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:14:51Z Snapshot: de759da059d73f0241b7bdc94b60e0d0be57ec7063a32d33422a0a03d58c8971 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420030/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1278617 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420030/000149315216008933/trgm-20151231.xml#586368 Filing: 000149315216008933 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

38 filings · 1,454 latest values · 1,454 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001420030, 1420030, TRGM, edgar:1420030

Also known as AFH Acquisition III, Inc., TARGETED MEDICAL PHARMA, INC., Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2015 2015-01-01 – 2015-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation